Lava Therapeutics N.V.: CORRECTING and REPLACING: LAVA Thera

Lava Therapeutics N.V.: CORRECTING and REPLACING: LAVA Therapeutics to Present its Bispecific Gamma Delta T Cell Engagers for Treatment of Cancer at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

UTRECHT, The Netherlands and PHILADELPHIA, Oct. 07, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by LAVA Therapeutics N.V. (Nasdaq: LVTX), please note that in the

Related Keywords

Philadelphia , Pennsylvania , United States , Netherlands , Catherine Day , Virtual International Conference On Molecular , Session Panel Discussion , International Conference , Molecular Targets , Cancer Therapeutics , Plenary Session , Panel Discussion , Cancer Therapeutic , Lava , Herapeutics , Kcorrecting , Eplacing , Present , Bispecific , Mamma , Delta , Fell , Engagers , Treatment , Dancer , 021 , Racr , Hortc , Irtual , Nternational , Conference , Olecular , Targets ,